AGIO
Price
$36.01
Change
-$0.12 (-0.33%)
Updated
Sep 5 closing price
Capitalization
2.1B
54 days until earnings call
RIGL
Price
$41.34
Change
+$1.21 (+3.02%)
Updated
Sep 5 closing price
Capitalization
741.53M
Interact to see
Advertisement

AGIO vs RIGL

Header iconAGIO vs RIGL Comparison
Open Charts AGIO vs RIGLBanner chart's image
Agios Pharmaceuticals
Price$36.01
Change-$0.12 (-0.33%)
Volume$1.48M
Capitalization2.1B
Rigel Pharmaceuticals
Price$41.34
Change+$1.21 (+3.02%)
Volume$466.97K
Capitalization741.53M
AGIO vs RIGL Comparison Chart in %
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. RIGL commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a Hold and RIGL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AGIO: $36.01 vs. RIGL: $41.34)
Brand notoriety: AGIO and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 168% vs. RIGL: 82%
Market capitalization -- AGIO: $2.1B vs. RIGL: $741.53M
AGIO [@Biotechnology] is valued at $2.1B. RIGL’s [@Biotechnology] market capitalization is $741.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileRIGL’s FA Score has 1 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • RIGL’s FA Score: 1 green, 4 red.
According to our system of comparison, both AGIO and RIGL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 4 TA indicator(s) are bullish while RIGL’s TA Score has 3 bullish TA indicator(s).

  • AGIO’s TA Score: 4 bullish, 6 bearish.
  • RIGL’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, RIGL is a better buy in the short-term than AGIO.

Price Growth

AGIO (@Biotechnology) experienced а -4.51% price change this week, while RIGL (@Biotechnology) price change was +6.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

AGIO is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGIO($2.1B) has a higher market cap than RIGL($742M). RIGL has higher P/E ratio than AGIO: RIGL (7.39) vs AGIO (3.20). RIGL YTD gains are higher at: 145.779 vs. AGIO (9.586). RIGL has higher annual earnings (EBITDA): 109M vs. AGIO (-456.28M). AGIO has more cash in the bank: 939M vs. RIGL (108M). AGIO has less debt than RIGL: AGIO (48.8M) vs RIGL (61M). RIGL has higher revenues than AGIO: RIGL (268M) vs AGIO (40.9M).
AGIORIGLAGIO / RIGL
Capitalization2.1B742M283%
EBITDA-456.28M109M-419%
Gain YTD9.586145.7797%
P/E Ratio3.207.3943%
Revenue40.9M268M15%
Total Cash939M108M869%
Total Debt48.8M61M80%
FUNDAMENTALS RATINGS
AGIO vs RIGL: Fundamental Ratings
AGIO
RIGL
OUTLOOK RATING
1..100
983
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
61
Fair valued
PROFIT vs RISK RATING
1..100
10073
SMR RATING
1..100
178
PRICE GROWTH RATING
1..100
5735
P/E GROWTH RATING
1..100
72100
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AGIO's Valuation (37) in the Biotechnology industry is in the same range as RIGL (61). This means that AGIO’s stock grew similarly to RIGL’s over the last 12 months.

RIGL's Profit vs Risk Rating (73) in the Biotechnology industry is in the same range as AGIO (100). This means that RIGL’s stock grew similarly to AGIO’s over the last 12 months.

RIGL's SMR Rating (8) in the Biotechnology industry is in the same range as AGIO (17). This means that RIGL’s stock grew similarly to AGIO’s over the last 12 months.

RIGL's Price Growth Rating (35) in the Biotechnology industry is in the same range as AGIO (57). This means that RIGL’s stock grew similarly to AGIO’s over the last 12 months.

AGIO's P/E Growth Rating (72) in the Biotechnology industry is in the same range as RIGL (100). This means that AGIO’s stock grew similarly to RIGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGIORIGL
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFNTX13.91N/A
N/A
Fidelity Advisor Asset Manager 40% M
BLDIX9.69N/A
N/A
BlackRock Managed Income Institutional
FFBFX30.91N/A
N/A
Emerald Finance & Bking Innovt Fd Inv
TSFCX12.84N/A
N/A
Touchstone Small Cap C
PAITX22.28N/A
N/A
T. Rowe Price International Stock Adv

AGIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGIO has been loosely correlated with LGND. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if AGIO jumps, then LGND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGIO
1D Price
Change %
AGIO100%
-0.33%
LGND - AGIO
49%
Loosely correlated
-0.59%
CRNX - AGIO
47%
Loosely correlated
+3.97%
SYRE - AGIO
46%
Loosely correlated
+0.06%
OCUL - AGIO
46%
Loosely correlated
+7.09%
ZYME - AGIO
46%
Loosely correlated
+6.89%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with MNMD. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+3.02%
MNMD - RIGL
41%
Loosely correlated
-0.11%
AGIO - RIGL
39%
Loosely correlated
-0.33%
RNA - RIGL
38%
Loosely correlated
+3.90%
FTRE - RIGL
37%
Loosely correlated
+10.66%
DNLI - RIGL
36%
Loosely correlated
+4.33%
More